(19)
(11) EP 4 815 963 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24898906.3

(22) Date of filing: 02.12.2024
(51) International Patent Classification (IPC): 
A61K 31/7056(2006.01)
A61P 5/46(2006.01)
 A61K 9/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/7056; A61P 5/46; A61K 31/7034
(86) International application number:
PCT/US2024/058109
(87) International publication number:
WO 2025/117962 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 01.12.2023 US 202363605200 P

(71) Applicant: Vogenx
Durham, NC 27713 (US)

(72) Inventors:
  • WILKISON, William, Owen
    Raleigh, NC 27615 (US)
  • CHEATHAM, Bentley
    Durham, NC 27705 (US)

(74) Representative: Jacobi, Markus Alexander 
Patentanwälte Isenbruck Bösl Hörschler PartG mbB Eastsite One Seckenheimer Landstrasse 4
68163 Mannheim
68163 Mannheim (DE)

   


(54) COMPOSITIONS AND METHODS FOR TREATING GLUCOSE-DEPENDENT INSULINOTROPIC PEPTIDE-DEPENDENT CUSHING'S SYNDROME